Answers are grounded in this paper and cite their sources.
Due to the limitations of standard microscopy, mixed Plasmodium infections represent a substantial and historically under-reported portion of India's malaria burden.With severe public health complications, molecular diagnostics now show high prevalence rates, dominated by Plasmodium falciparum and Plasmodium vivax co-infections.Efficient management depends on accurate species identification.For example, Plasmodium falciparum needs early artemisinin-based combination therapies (ACTs) to prevent severe disease, whereas Plasmodium vivax and Plasmodium ovale require chloroquine in combination with hypnozoitocidal agents (primaquine/tafenoquine) to prevent relapses.Interspecies dynamics, which can worsen disease severity and complicate therapeutic outcomes through multi-drug resistance, increase the risk of misdiagnosis and treatment failure.Through genetic recombination in mosquitoes, mixed infections hasten the evolution of anti-malarial resistance and sustain invisible transmission reservoirs, undermining efforts to eliminate malaria.To develop a broad-spectrum vaccine that is effective against all human-infecting species, including emerging zoonotic threats, it is crucial to pinpoint conserved targets, accomplished during research on these complex infections.Therefore, species-specific interventions and improved molecular surveillance are key in India's malaria control strategy.
No takes yet. Share an insight, caveat, or question.
Siwal et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: